Xiaoxu Jiang
Finanzdirektor/CFO bei Shanghai NewMed Medical Co., Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yu QifengY | M | 45 |
Shanghai NewMed Medical Co., Ltd.
 Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 9 Jahre |
| Feng Mao Hua | M | 56 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Jiang Nan Cai | M | 67 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Yu Feng Zheng | M | 50 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Tao Qin | M | 51 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 9 Jahre |
| Xia Yan Yang | F | 42 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Xuyang Xie | M | 48 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 8 Jahre |
| Guo Wei Wang | M | 63 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 4 Jahre |
| Ming King Chiu | M | 47 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Jie Zhang | M | 59 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 9 Jahre |
| Kai Liu | M | 38 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Xiu Lan Cheng | F | 45 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Xiao Yong Yu | M | 51 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Xiantao Wen | M | 46 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 7 Jahre |
| Robert Philibert | M | 63 |
University of Iowa
| 26 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Chan | M | - |
Piper Jaffray Asia Securities Ltd.
| 2 Jahre |
| Mark Alfred Marostica | M | 63 |
Piper Jaffray Asia Securities Ltd.
| 3 Jahre |
| Doug Weih | M | - |
University of Iowa
| 11 Jahre |
| Casey Albert | F | - |
Columbia Business School
| 3 Jahre |
| John Mickelson | M | - |
University of Iowa
| 8 Jahre |
| Jay Radtke | M | - |
Columbia Business School
| 1 Jahre |
| Eugene Song | M | - |
Columbia Business School
| 2 Jahre |
| Gregory Howard Smith | M | - |
Columbia Business School
| 2 Jahre |
| Luv Dinesh Parikh | M | 48 |
Columbia Business School
| 2 Jahre |
| Rachana Vashi | F | - |
Columbia Business School
| 2 Jahre |
| Ameenesh Shah | M | - |
Columbia Business School
| 2 Jahre |
| John Edward Hentschel | M | 51 |
Columbia Business School
| 2 Jahre |
| Brad Arkin | M | - |
Columbia Business School
| 2 Jahre |
| Kevin Frisz | M | - |
Columbia Business School
| 2 Jahre |
| Palak S. Pathak | F | - |
Columbia Business School
| 2 Jahre |
| Peter Berweger | M | 54 |
Columbia Business School
| 3 Jahre |
| Michael Lythcott | M | - |
Columbia Business School
| 2 Jahre |
| Jenn Lynch | F | - |
Columbia Business School
| 1 Jahre |
| Maxim Lapin | M | 44 |
Columbia Business School
| 2 Jahre |
| Christopher Folkemer | M | - |
Columbia Business School
| 2 Jahre |
| Jyotsna V. Bean | F | - |
Columbia Business School
| 2 Jahre |
| Karen R. Abraham | F | - |
Columbia Business School
| 2 Jahre |
| William Bardeen | M | 50 |
Columbia Business School
| 2 Jahre |
| Michele Ruta | M | - |
Columbia Business School
| 3 Jahre |
| Susan Young | F | - |
Columbia Business School
| 2 Jahre |
| Mike McQuigg | M | 73 |
Columbia Business School
| 2 Jahre |
| Loulwa Al-Bakr | F | 47 |
Columbia Business School
| 2 Jahre |
| Zachary Block | M | - |
Columbia Business School
| 2 Jahre |
| Artem Mikhlin | M | - |
Columbia Business School
| 2 Jahre |
| Thomas Harris | M | - |
Columbia Business School
| 1 Jahre |
| Danny Akerman | M | - |
Columbia Business School
| 1 Jahre |
| Rong Feng Jiang | M | 47 |
Columbia Business School
| 4 Jahre |
| Jason Heartwood phillips | M | - |
Columbia Business School
| 2 Jahre |
| Strauss Marc | M | - |
Columbia Business School
| 2 Jahre |
| Everardo Camacho | M | - |
Columbia Business School
| - |
| Medea Nocentini | F | - |
Columbia Business School
| 2 Jahre |
| Alan Au | M | - |
Columbia Business School
| 2 Jahre |
| Jing Hua Jin | F | 53 |
Columbia Business School
| 2 Jahre |
| Erica Duignan | F | - |
Columbia Business School
| 2 Jahre |
| Ian Ying Woo | M | 51 |
Columbia Business School
| 2 Jahre |
| Rui Zhao | M | - |
Columbia Business School
| 3 Jahre |
| Pamela Applefeld | F | - |
Columbia Business School
| 1 Jahre |
| Jon Gordon | M | - |
Columbia Business School
| 2 Jahre |
| David Colin Getsie | M | - |
Columbia Business School
| 2 Jahre |
| Yaron Sadan | M | - |
Columbia Business School
| 2 Jahre |
| Richard Fitzgerald | M | - |
Columbia Business School
| 2 Jahre |
| Sunil Haren Thakor | M | - |
Columbia Business School
| 2 Jahre |
| Vic Singh | M | - |
Columbia Business School
| 2 Jahre |
| Jim Kim | M | - |
Columbia Business School
| 2 Jahre |
| Hans Nicholas Appleyard Heilbut | M | - |
Columbia Business School
| 2 Jahre |
| Genevieve Sangudi | F | 47 |
Columbia Business School
| 2 Jahre |
| Luis Amadeo | M | - |
Columbia Business School
| 2 Jahre |
| Andrew Cavanna | M | 50 |
Columbia Business School
| 2 Jahre |
| Christophe Browne | M | 46 |
Columbia Business School
| 2 Jahre |
| Nigel Winston Frankson | M | - |
Columbia Business School
| 2 Jahre |
| Christopher Wade Robertson | M | - |
Columbia Business School
| 2 Jahre |
| Eric Wilkins | M | - |
Columbia Business School
| 2 Jahre |
| Stephen Lloyd Fisch | M | - |
Columbia Business School
| 2 Jahre |
| Sourabh Banerji | M | - |
Columbia Business School
| 2 Jahre |
| Robin Singh Chhabra | M | - |
Columbia Business School
| 2 Jahre |
| Jared Grusd | M | 49 |
Columbia Business School
| 2 Jahre |
| Garrett Edson | M | - |
Columbia Business School
| 2 Jahre |
| Ingrid Saukaitis Dyott | F | - |
Columbia Business School
| 2 Jahre |
| Abbas M. Hasan | M | - |
Columbia Business School
| 1 Jahre |
| John R. Weber | M | - |
Columbia Business School
| 2 Jahre |
| Gabriel Kra | M | - |
Columbia Business School
| 2 Jahre |
| Rado Bradistilov | M | - |
Columbia Business School
| 2 Jahre |
| Philip Stephen Riley | M | - |
Columbia Business School
| 2 Jahre |
| David B. Marshak | M | - |
Columbia Business School
| 2 Jahre |
| Jesse Hertzberg | M | - |
Columbia Business School
| - |
| Dean B. Rostovsky | M | - |
Columbia Business School
| 2 Jahre |
| Su Hai Ji | M | 48 |
Columbia Business School
| 2 Jahre |
| Robert Klein | M | 48 |
Columbia Business School
| 2 Jahre |
| Sunit Gogia | M | - |
Columbia Business School
| 1 Jahre |
| Tim Mullany | M | 48 |
Columbia Business School
| 2 Jahre |
| Fabian Tenenbaum | M | 50 |
Columbia Business School
| 2 Jahre |
| Eli Casdin | M | 51 |
Columbia Business School
| 1 Jahre |
| Alfonso Portillo | M | - |
Columbia Business School
| 2 Jahre |
| Christopher B. Taube | M | - |
Columbia Business School
| 2 Jahre |
| Jayen Dalsukh Madia | M | - |
Columbia Business School
| 2 Jahre |
| Trang-Thu Tran | F | - |
Columbia Business School
| 2 Jahre |
| H. Byun | M | - |
Columbia Business School
| 2 Jahre |
| Paul Lipson | M | - |
Columbia Business School
| 2 Jahre |
| Ron Gonen | M | 49 |
Columbia Business School
| 2 Jahre |
| Pete Saladino | M | - |
Columbia Business School
| 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 84 | 84,00% |
| China | 14 | 14,00% |
| Hong Kong | 2 | 2,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Xiaoxu Jiang
- Persönliches Netzwerk
